Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06448806
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-05-21
Brief Title:
Mobile Health M-health Intervention to Reduce the Epigenetic Signature in Metabolic Syndrome MetS
Sponsor:
Aga Khan University
Organization:
Aga Khan University
Study Overview
Official Title:
Epigenetic Signature of Advance Glycation End Products AGE and Skin Autofluorescence As a Risk Predictor in Metabolically Healthy and Unhealthy Obese Adults
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this interventional study is to learn about the improvement in body composition effects of lifestyle intervention in subjects with metabolic syndrome The main question it aims to answer is
Does life style intervention lower body fat and gene methylation levels in subjects with metabolic syndrome Participants will answer survey questions and get blood and body composition testing done at day 0 at 6 months and 12 months Keep a diary of their food and activity and the number of times they use mobile health application
Does life style intervention lower body fat and gene methylation levels in subjects with metabolic syndrome Participants will answer survey questions and get blood and body composition testing done at day 0 at 6 months and 12 months Keep a diary of their food and activity and the number of times they use mobile health application
Detailed Description:
This is same as above
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None